Get started
Aarti Drugs LimitedAarti Drugs LimitedAarti Drugs Limited

Aarti Drugs Limited

No trades
See on Supercharts
OverviewFinancialsNewsDocumentsIdeasDiscussionsTechnicalsForecastSeasonalsETFs

AARTIDRUGS trade ideas

AARTIDRUGS : Swing Pick ( 1:2 RR Trade)#AARTIDRUGS #momentumstock #breakoutstock AARTIDRUGS : Swing Trade >> Good Setup (1: 2 Risk Reward Trade) >> Good Strength in Stock >> Volumes Dried up >> Low PE Stock Swing Traders can lock profit at 10% and keep Trailing Please Boost, comment and follow us for more Learnings. Disc : Charts shared are for learning purpose only, not a Trade recommendation. Do your own research and consult your financial advisor before taking any position.
NSE:AARTIDRUGSLong
by moneyfesttrading
Aarti Drugs Ltd (Daily Timeframe) - Potential BreakOutThe resistance zone (560-570) was breached only once , and thereafter, the stock was in a downtrend for a prolonged duration. Recent past, the stock has been forming Higher Lows & a buildup in volume in the past few days. The stock gained almost 19.5% over the last few days, assisted by huge volume. On Jul 15, the stock BrokeOut of a major resistance with huge volume, and today it tried to breach the long-term resistance. The Short-term EMAs are in PCO state as well as a Golden Cross-over has formed few days back, which indicates further uptrend. We should monitor the stock in the coming days for its price action to take a call.
NSE:AARTIDRUGSLong
by Learn_with_Pth0mas
AARTIDRUGS | Inverted Head & ShouldersAarti Drugs (#NSE: #AARTIDRUGS) based on the chart and investment notes. 🔍 Technical Analysis: 🧠 Pattern: Inverted Head & Shoulders (H&S) – Classic reversal pattern. Breakout confirmed above the neckline (~₹496), now retesting and holding above ₹523. Projection: Neckline to Head depth: ~₹184 Target: ₹496 + ₹184 = ₹680–685 🔑 Key Levels: Support: ₹482(neckline), then ₹440–450 Resistance: ₹644.50 (historical), then ₹683–685 (pattern target) Volume: Decent rise during breakout, confirming strength. 📉 Risk: If the price breaks back below ₹496 with volume, the setup weakens. Keep stop-loss below ₹468 swing low. 💹 Fundamental Insights : Metric Comment 🏗️ Capex ₹600 Cr completed, expansion nearly done 🔁 Turnover 2.5x → Significant revenue efficiency 💰 Revenue Impact ₹1500 Cr new capacity to kick in 📈 Margin Expansion - Utilization to improve → better margins 💹 Return Ratios RoCE and RoE likely to improve 💵 Shareholder Returns 15–30% of PAT to be distributed 🧠 Interpretation: Capex cycle ending = lower costs + higher output. ROCE + RoE expansion + PAT payout = strong re-rating candidate. Operating leverage + volume growth = multi-quarter compounding story. 📆 What to Expect Next Week (22–26 July 2025): Scenario Expectation 📈 Bullish (likely) Follow-through rally toward ₹550–₹575 in short term 🔄 Sideways Retest ₹496–510 zone before heading higher 📉 Bearish (low chance) Breakdown below ₹496 would delay the up move ✅ Summary: Factor Signal Chart ✅ Inverted H&S breakout Fundamentals ✅ Strong capex-led growth + margin + return expansion Volume ✅ Supporting breakout Risk Management Use SL below ₹468 Short-term Target ₹550–575 Medium-term Target ₹644–683
NSE:AARTIDRUGSLong
by DailyCharts03
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES? - Take BTST trades at 3:25 pm every day - Try to exit by taking 4-7% profit of each trade - SL can also be maintained as closing below the low of the breakout candle Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and the rest of the time they either consolidate or fall Trendline Breakout in AARTIDRUGS BUY TODAY SELL TOMORROW for 5%
NSE:AARTIDRUGS
by Kapil-Mittal
4
AARTI DRUGS technical analysisAarti Drugs Ltd. (NSE: AARTIDRUGS) is currently priced at INR 419.85. The company operates in the pharmaceutical sector, specializing in the manufacturing of bulk drugs, active pharmaceutical ingredients (APIs), and formulations. Key Levels Support Level: INR 302.50 Swing Level: INR 437.35 Possible Upside Levels: INR 586.30, INR 881.60, INR 1,036.45, INR 1,233.70 Technical Indicators RSI: The Relative Strength Index (RSI) is currently at 51.01, indicating neutral momentum. RSI values between 30 and 70 typically suggest that the stock is neither overbought nor oversold. Volume: The trading volume stands at 12.36M, reflecting moderate activity. Higher volume during price increases signals strong buying interest, while lower volume during declines suggests weak selling pressure. Sector and Market Context Aarti Drugs Ltd. operates within the pharmaceutical sector, which has demonstrated resilience and growth potential, particularly in the wake of increased healthcare demand. The broader market trends indicate cautious optimism, with investors seeking stable and growth-oriented stocks. The pharmaceutical sector is expected to benefit from ongoing healthcare advancements, regulatory support, and increasing demand for APIs and formulations. However, global economic conditions and sector-specific challenges may influence stock performance. Risk Considerations Regulatory Changes: Any modifications in pharmaceutical regulations or policies could impact the company’s operations and profitability. Market Competition: The pharmaceutical space is highly competitive, with new entrants and existing players posing challenges. Economic Factors: Macroeconomic conditions, such as inflation and currency fluctuations, can influence the stock’s performance. Company-Specific Risks: Operational challenges, product recalls, or negative clinical trial results can adversely affect the stock price. Analysis Summary Aarti Drugs Ltd. exhibits growth potential within the pharmaceutical sector, supported by its strong presence in API manufacturing. The stock is currently in a neutral momentum phase, with key levels indicating possible upside opportunities. Investors should weigh the risks associated with market volatility, regulatory changes, competitive pressure, and economic factors. A balanced approach, considering both growth prospects and associated risks, is advisable for making informed investment decisions.
NSE:AARTIDRUGSLong
by TechnicalAnalystSucrit
Trend Reversal in Aarti DrugsNSE:AARTIDRUGS is showing signs of Trend Reversal Although Still below 100 DSMA and Key Levels if it closes above it and Sustains Those Levels We can see New Highs Quickly, as it broke a Major Trendline with MACD Showing Buy Signal. Today it increased by 12% on the back of US FDA Clearance of its API Facility at Tarapur. 📌Thank you for exploring my idea! I hope you found it valuable. 🙏FLLOW for more 👍BOOST if useful ✍️COMMENT Below your views. Meanwhile, check out my other stock ideas below until this trade is activated. I would love your feedback. Disclaimer: This analysis is intended solely for informational and educational purposes and should not be interpreted as financial advice. It is advisable to consult a qualified financial advisor or conduct thorough research before making investment decisions.
NSE:AARTIDRUGS
by Karanshah137
Aarti Drugs - Fibonacci Retracement ToolWe have used fibonacci retracement tool to check the retracement of price. The price has reached 0.382 and once cross this, we can see change of trend. We can also see the EMA20 about to cross EMA200, which will show bullishness in the stock. The fibonacci at 0.5 level, 0.618 as resistances, and on crossing each resistance we can see price moving up. Other factors: 1. MACD about to be positive 2. RSI is a bit down, however, we can expect it to move above 3. Volume candles; buy candles are bigger than sell candles "Clean Charts, Easy Charts" Learning & Earning!! Cheers!!
NSE:AARTIDRUGSLong
by Cleaneasycharts
1
AARTI DRUGS - Price Observation & OverviewPrice Observation & Overview: 1. Currently reacting from the supply zone and trendline. 2. Volumes are dry! 3. Earnings are weak. 4. Buying strength is lacking at the moment. Plan: 1. Wait and observer. 2. Will try to update a follow-up review post in the next week if found anything interesting and significant... - Stay tuned for further insights, updates and trade safely! - If you liked the analysis, don't forget to leave a comment and boost the post. Happy trading! Disclaimer: This is NOT a buy/sell recommendation. This post is meant for learning purposes only. Please, do your due diligence before investing. Thanks & Regards, Anubrata Ray
NSE:AARTIDRUGS
by SuperNova396
AARTI DRUGS - Monthly Chart - LongAarti Drugs Ltd (NSE: AARTIDRUGS) has been trading within a well-defined parallel channel on the monthly timeframe since 2009. The stock is currently at the bottom of the channel, having successfully retested the channel support. This retest could signify a potential bounce, presenting a long-term buying opportunity. The RSI is also on an upward trajectory. Sharing this analysis for Long-Term investors. Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always conduct your own research before making any investment decisions.
NSE:AARTIDRUGSLong
by gurinder1988
4
AARTIDRUGS [descending triangle pattern bullish]I try new swing trading strategy .. if it work then explain everything to you . all trg open , SL always paid 1) Descending Trendline Breakout: The stock price has broken above a descending trendline, which is a bullish signal. This indicates a potential change in trend from bearish to bullish. 2)Support Zone : There is a significant support zone marked in red between approximately 440 and 470. The stock has tested this zone multiple times and has recently bounced back, suggesting strong support. 3)The stock has just broken out of the descending trendline and is currently around 511.70. This breakout needs to be confirmed with continued upward movement and volume is above of 20ma line like good signal . 4)Based on the chart and technical analysis provided, Aarti Drugs shows potential bullish momentum with targets at 560 and 620. However, it is important to monitor the stock for continued upward movement and volume to confirm the breakout. Keep an eye on the support zones as well to manage risk effectively. for MORE check in my TradingView ID If You LIKE👌👌 MY Idea ......Boost.🔥🔥🔥.. its. "Disclosure : I am not Sebi-registered." This channel is for only educational purpose. Any profit/loss, I am not responsible. Before taking any trade on our charts / calls, please consult your financial advisors. Thanks
NSE:AARTIDRUGSLong
by asAMOLSUTAR